C20ORF30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.250000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.216800E-01
Normal-vs-Stage2
4.229000E-01
Normal-vs-Stage3
1.107810E-01
Normal-vs-Stage4
5.834200E-01
Stage1-vs-Stage2
3.459600E-01
Stage1-vs-Stage3
4.336100E-02
Stage1-vs-Stage4
6.519200E-01
Stage2-vs-Stage3
1.699170E-01
Stage2-vs-Stage4
6.512200E-01
Stage3-vs-Stage4
1.524000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.589200E-01
Normal-vs-AfricanAmerican
1.979610E-01
Normal-vs-Asian
4.419400E-01
Caucasian-vs-AfricanAmerican
6.700600E-01
Caucasian-vs-Asian
5.398800E-01
AfricanAmerican-vs-Asian
9.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.264000E-01
Normal-vs-Female
5.303000E-01
Male-vs-Female
5.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.545800E-01
Normal-vs-Age(41-60Yrs)
7.424000E-01
Normal-vs-Age(61-80Yrs)
4.823000E-01
Normal-vs-Age(81-100Yrs)
2.306200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.500000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.508000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.363000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.898000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.134800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.086600E-01
Normal-vs-Daily Drinker
2.937200E-01
Normal-vs-Weekly Drinker
4.311400E-01
Normal-vs-Occasional Drinker
9.251200E-01
Normal-vs-Social Drinker
8.551600E-01
Non Drinker-vs-Daily Drinker
9.790800E-01
Non Drinker-vs-Weekly Drinker
4.829000E-01
Non Drinker-vs-Occasional Drinker
1.177790E-02
Non Drinker-vs-Social Drinker
1.233760E-01
Daily Drinker-vs-Weekly Drinker
5.410600E-01
Daily Drinker-vs-Occasional Drinker
3.071800E-02
Daily Drinker-vs-Social Drinker
1.844400E-01
Weekly Drinker-vs-Occasional Drinker
1.439430E-01
Weekly Drinker-vs-Social Drinker
4.685400E-01
Occasional Drinker-vs-Social Drinker
6.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.160200E-01
Normal-vs-Grade 2
8.350400E-01
Normal-vs-Grade 3
8.088800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.304000E-01
Grade 1-vs-Grade 3
6.636000E-01
Grade 1-vs-Grade 4
5.160200E-01
Grade 2-vs-Grade 3
5.740200E-01
Grade 2-vs-Grade 4
8.350400E-01
Grade 3-vs-Grade 4
8.088800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.635800E-01
Normal-vs-NonDiabetic
6.083400E-01
Diabetic-vs-NonDiabetic
1.475990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.539300E-03
Normal-vs-NoPancreatitis
5.931200E-01
Pancreatitis-vs-NoPancreatitis
2.365000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.218000E-01
Normal-vs-N1
4.733000E-01
N0-vs-N1
7.376200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.884200E-01
Normal-vs-TP53-NonMutant
5.673800E-01
TP53-Mutant-vs-TP53-NonMutant
7.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
